mardi 3 octobre 2017

Onco Actu du 3 octobre 2017

1. Biologie

By Decoding How HPV Causes Cancer, Researchers Find a New Potential Treatment Strategy [GUMC]

3.1.1 Prévention - Tabac - e-cigs

Switching to e-cigarettes could save 6.6 million American smokers: researchers [Reuters]

4.12 Biopsies liquides

Liquid Biopsies May Help Predict Response to Immune Checkpoint Inhibitors [AACR]

5. Traitements

Our milestones: A radical change that improved breast cancer surgery [Cancer Research UK]

5.1 Traitements - Pré-clinique

New target for treating “undruggable” lung cancer [MIT News]

5.10 Traitements - Essais

ASCO and Friends of Cancer Research Release Comprehensive Recommendations to Broaden Eligibility Criteria for Cancer Clinical Trials [ASCO]

5.12.7 Immunothérapies - vaccins

Personalized Cancer Vaccine Company Raises $93 Million [Forbes]

5.2 Pharma

Seattle Genetics Receives FDA Breakthrough Therapy Designation for ADCETRIS® (Brentuximab Vedotin) in Frontline Advanced Hodgkin Lymphoma [Seattle Genetics]

Seattle Genetics and Takeda Announce Publication in Blood of Final Long-Term Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma [Seattle Genetics]

KSQ Bets on CRISPR-Juiced Drug Discovery With $76M and Ex-Genzyme CEO Meeker [Xconomy]

CRISPR-Focused Biotech Co-Founded By Forbes Under 30 Alumnus Raises $76 Million [Forbes]

Genzyme vet David Meeker takes helm at stealthy KSQ with $76M and a new map for drug discovery [EndPoints]

5.2.1 Pharma - Partenariats

Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal [Xconomy]

5.2.3 Pharma - économie

Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio [Xconomy]

Top scientists and BD execs craft Cullinan, a $150 million R&D portfolio shop focused on cancer [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

General Court finds no fault in 2011 appointment procedure of EMA Executive Director [EMA]

EU drugs head fears delays, health hazards as agency uprooted [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

FDA Approves New Treatment Option for Breast Cancer [Cancer Research Catalyst]

5.4 Traitements - Economie

5 ways pharma is misleading the public on the cost of prescription drugs [STAT]

6. Lutte contre les cancers

Overshadowed by pink: Breast cancer is important, but so are other cancers [STAT]

6.3 Associations/Fondations

Non-profit Alliance for Patient Access uses journalists and politicians to push Big Pharma’s agenda [HealthNewsReview]

6.7.2 Applis

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams [Roche]

6.9 Controverses

When can correlation equal causation? [The Logic of Science]